JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Ophthalmology Section DOI : 10.7860/JCDR/2021/48317.14943
Year : 2021 | Month : May | Volume : 15 | Issue : 05 Full Version Page : NC12 - NC15

Correlation between Intraocular Pressure and Visual Field Loss in Primary Open Angle and Primary Angle Closure Glaucoma: A Cross-sectional Study

VR Raji1, Susan Philip2, S Ambily3

1 Assistant Insurance Medical Officer, Department of Ophthalmology, Insurance Medical Services, Trivandrum, Kerala, India.
2 Professor, Department of Ophthalmology, Regional Institute of Ophthalmology, Trivandrum, Kerala, India.
3 Associate Professor, Department of Ophthalmology, Regional Institute of Ophthalmology, Trivandrum, Kerala, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Susan Philip, Pavoor House, Nanthen Code, Trivandrum-695003, Kerala, India.
E-mail: drsusangeorge@gmail.com
Abstract

Introduction

Glaucoma is characterised by structural damage to optic nerve head with corresponding visual field defects and often associated with increased Intraocular Pressure (IOP). It may be broadly classified as Primary Angle Closure Glaucoma (PACG) and Primary Open Angle Glaucoma (POAG). It is one of the leading causes of global blindness, and a major proportion occurs in Indian population.

Aim

To study the correlation between pretreatment IOP and extent of visual field loss in PACG and POAG.

Materials and Methods

A cross-divtional observational study was carried out in Regional Institute of Ophthalmology, Trivandrum, Kerala, India from April 2016 to May 2017. Newly diagnosed cases of PACG (25 patients-13 males, 12 females, mean age 58.72±10.07 years) and POAG (85 patients- 45 males, 40 females, mean age 60.28±10.42 years) underwent a detailed glaucoma evaluation which included IOP measurement with Goldmann applanation tonometer and visual field testing using Humphrey Field Analysis (HFA) 24-2 pattern. Mean Deviation (MD), Pattern Standard Deviation (PSD) and Advanced Glaucoma Intervention Score (AGIS) was calculated from reliable visual field test result. All data were coded and entered in statistical software, Statistical Package for Social Sciences (SPSS) version 16.0 for analysis. The correlation between pretreatment IOP and visual field loss in patients with PACG and POAG was determined by Pearson correlation of coefficient (r).

Results

Amongst the total 110 patients of this study, 25 patients were of PACG while POAG were in 85 patients. A significant correlation between pretreatment IOP and the extent of visual field loss in PACG was noted. There was no significant correlation in POAG. Linear regression analysis demonstrated a significant positive correlation between IOP and AGIS score in PACG r=0.805, p<0.001), not in POAG (r=0.026, p=0.816). Correlation between IOP and MD was statistically significant in PACG (r=0.812, p<0.001) but not in POAG (r=-0.058, p=0.597). The correlation between IOP and PSD was not statistically significant in both groups (p-value=0.450).

Conclusion

A significant correlation between IOP and visual field loss in PACG indicates that extent of visual field damage can be controlled by controlling IOP alone in PACG. The correlation between the pretreatment IOP and visual field loss in POAG is not statistically significant which agrees with the current proposed pathophysiology of optic neuropathy in which multiple factors influence in addition to IOP.

Keywords

Introduction

Glaucoma is the second most common cause of blindness worldwide. In India, approximately 11.2 million adults above 40 years are estimated to have glaucoma; 6.48 million with POAG and 2.54 million with PACG [1]. Glaucoma is an irreversible optic neuropathy with corresponding visual field defects which progress to blindness unless timely intervention is done. An important risk factor is the level of IOP. It is determined by the aqueous humour drainage which in turn depends on the status of angle of anterior chamber. Angle structures are occluded in PACG whereas they are open in POAG although there is sclerosis of trabecular meshwork.

Goldmann Applanation Tonometry (GAT) has been considered as the most accurate method for IOP measurement due to its low intra- and inter-observer variability [2]. Gonioscopy allows us to examine the angle of anterior chamber and forms part of complete ophthalmic examination and it is mandatory for the diagnosis and management of glaucoma. Gonioscopy permits the identification of eyes at risk for closure and detects angle abnormalities [3].

Since visual field loss is the morbid sequalae, it should be evaluated and graded to understand the severity of disease. Humphrey Field Analyser (HFA) is used for this purpose which employs the principle of static perimetry. The Full Threshold strategy is the standard technique in static threshold perimetry and used in most glaucoma-related clinical trials, which is followed here [4].

A study in South-east Asia suggested a stronger correlation between initial IOP which was recorded before starting treatment and the severity of visual field loss in PACG than POAG. This indicates that IOP may be more important as a causative factor for optic nerve damage in PACG than it is in POAG [5]. Since, IOP is the most important modifiable risk factor to halt the progression of optic neuropathy and consequent visual field loss, it was studied in the present population. The disease pathology in PACG is likely to be entirely dependent on intraocular pressure whereas it is unlikely in POAG [6]. While IOP-lowering is a mainstay of glaucoma therapy, and a very successful “neuro-protectant” in itself, complementary approaches to glaucoma therapy is essential to prevent visual deterioration [7]. The study was done to assess the correlation between IOP and visual field loss in PACG and POAG.

Materials and Methods

This cross-sectional observational study of newly diagnosed cases of PACG and POAG above 40 years was done in Regional Institute of Ophthalmology, Trivandrum, Kerala, India over a period of one year from April 2016 to May 2017. After obtaining clearance from Institutional Ethics Committee (IEC no/49/16/HEC/RIOTVPM) the study was done according to following criteria.

Inclusion criteria: Newly diagnosed cases of PACG and POAG above 40 years who attended glaucoma clinic for complete ocular examination and visual field analysis were included in the study after obtaining the informed consent.

Exclusion criteria: Secondary glaucomas, acute congestive glaucoma, patients on anti-glaucoma medications and topical steroids and those with history of ocular surgery or trauma in the affected eye. Patients with refractive error higher than 5D myopia or hypermetropia and unreliable visual fields even after repeated testing were also excluded.

Sample size calculation: Sample size is calculated using the formula

where r is the Pearson correlation coefficient. t=(z1-α/2+z1-β)=√7.84

α=5%, β=20%

In PACG, sample size was 21, according to r value of 0.41 for AGIS score and significance level of 95%. In POAG, sample size calculated as 85, according to r value of 0.21 for MD and significance level 95% based on a reference study [5].

Procedure

Patients whose IOP was recorded more than 21 mmHg in either eye was evaluated further by following examinations and those who satisfy inclusion criteria selected for study. Their age, gender, ocular history, medical history and family history of glaucoma were noted. The Best Corrected Visual Acuity (BCVA) assessed using Snellens chart and baseline IOP was recorded with GAT. Colour vision was recorded using Ishihara chart. The calibration of tonometer was done by glaucoma surgeon on weekly basis. A slit lamp, biomicroscopy and indentation gonioscopy using posner lens was done. Gonioscopy was done at a dim illumination with a very narrow slit. Care was taken to avoid light in the pupillary area. The angle structures were examined at 16 times magnification. An occludable angle was defined as one in which the posterior pigmented trabecular meshwork was seen less than 90 degree of angle without indentation [8].

Optic nerve head and Retinal Nerve Fibre Layer (RNFL) was assessed using 90 D lens and cup disc ratio was estimated. Enlargement of vertical cup disc ratio above 0.6 or asymmetry of 0.2, presence of bayonetting, laminar dot sign, beta peripapillary atrophy, nasal shift of vessels and baring of circumlinear vessels were suggestive of glaucomatous optic neuropathy, hence their visual fields were evaluated [9].

Two reliable visual field test were done using HFA Swedish Interactive Threshold Algorithm (SITA) standard, 24-2 pattern (with full threshold strategies, fixation loss less than 20%, false positive and false negatives less than 33%). Refractive correction is used during HFA. The more reliable of two baseline visual field is selected. A size III white stimulus with the foveal threshold test turned on was used. The pupil diameter was more than 2 mm. If necessary, the pupil was dilated before the test. An appropriate age-related plus-power lens was added to the distance refraction for best-corrected vision. The room lights were dimmed without direct light falling on the patient. The patients were allowed to blink and to maintain fixation. Test results were checked for reliability. If the test was unreliable, it was repeated.

The Mean Deviation (MD) reflects overall depression of field, with normal values between 0 to -2 dB. The values of the test are added and divided on the number of test locations. Thus the mean value of the test is obtained.The difference between this value and normal represents MD [10]. Pattern standard deviation is a measurement that indicates a difference in the sensitivity of adjacent tested points. In glaucoma patients as irregular depression of visual field sensitivity progresses, PSD values increase [11]. Severity of visual field loss was scored using AGIS scoring system [12]. In the AGIS scoring system, the 24-2 area of the visual field was divided into three areas: the nasal, superior hemifield and inferior hemifield areas. The amount of sensitivity loss (total deviation) necessary to be considered abnormal varies from 5 to 9 dB depending on the location. A nasal defect is a group of three or more contiguous depressed points that may cross the horizontal midline. A nasal step is one contiguous point or more in the superior nasal area without any depression in the opposite nasal area and vice versa. Any one defect results in a score of 1. If four or more of the nasal test points have defect depths of 12 dB or more, a score of 2 is marked. The superior and inferior hemifields are scored separately. The number of groups of three or more contiguous depressed points is identified and the total number of points within these groups was summed. A score of one for a total of 3 to 5 points, two for 6 to 12 points, three for 13 to 20 points, and four for more than 20 points were given. Additional scores are given according to the defect depth. A score of 1, 2, 3, 4, or 5 is added respectively if atleast half the points are depressed by ≥12, ≥16, ≥20, ≥24, or ≥28 decibels. A maximum score of 9 is given to each hemifield, and a maximum score of 2 to the nasal area. Thus resulting in a total score that can range from 0 (no field loss) to 20 (end stage) [13].

The PACG was diagnosed when the angle was occludable and there was visual field loss according to AGIS scoring system; POAG was diagnosed when they had open angle on gonioscopy with glaucomatous visual field loss and no apparent secondary cause. Anterior Chamber Depth (ACD) and Axial Length (AL) measurement was done with ultrasound A scan; central corneal thickness was measured using pachymeter.

Statistical Analysis

Data analysis was done for the eye with higher IOP and the more reliable visual field was selected. It was carried out using SPSS version 16. Baseline demographic and clinical data were presented as mean±SD. Linear regression analysis was used to assess the correlation between baseline IOP with MD, PSD and AGIS score data. Since values didn’t follow normal distribution, Spearman Correlation was used.

Results

A total of 110 patients were enrolled in the study; 25 belonged to PACG group and 85 were POAG patients. In both the PACG and POAG group, maximal incidence was between 5th and 7th decade with mean age of 58.72±10.07 years in PACG and 60.28±10.42 years in POAG. The gender difference was less in PACG 52% and in POAG 52.9% were males [Table/Fig-1]. Co-existent diabetes mellitus and hypertension were more in POAG group (40% vs 47.05%; 32% vs 48.24%) [Table/Fig-2].

Demographic parameters of all subjects.

Demographic variablesPACG group (n=25)POAG group (n=85)
Age (years)Frequency (n)Frequency (n)
≤55928
56-701342
>70315
Sex ratio
Male:female13:1245:40
Total2585

PACG: Primary angle closure glaucoma; POAG: Primary open angle glaucoma


Co-morbidities in subjects.

TypeNDMHTN
PACG25108
POAG854041

DM: Type 1 Diabetes mellitus; HTN: Systemic hypertension


A positive family history was considerably higher in POAG as compared to PACG group (41.18% vs 16%) [Table/Fig-3].

Data of positive family history.

Family history of glaucomaPACG (n)POAG (n)
Yes435
No2150
Total2585

The distribution of BCVA and colour vision in PACG and POAG is shown in [Table/Fig-4]. The mean AL was shorter in PACG (21.59±1.15 vs 23.55±0.79 mm) with shallower mean ACD (2.30±0.44 vs 2.57±0.28 mm) [Table/Fig-5,6].

Distribution of cases according to visual impairment; Best Corrected Visual Acuity (BCVA) and colour vision.

Visual analysisPACG (n)POAG (n)
BCVA
6/6419
6/9423
6/12720
6/18214
6/2434
6/3634
6/6021
Colour vision
Normal2072
Defective513

(n=25 in PACG group; n=85 in POAG group)


Ocular biometrics assessment in PACG.

PACGNMinimumMaximumMeanSD
Age (years)25407958.7210.07
IOP (mm Hg)25294233.563.40
CCT (mm)25501569531.9614.15
ACD (mm)251.713.752.300.44
AL (mm)2520.0823.9221.591.15

CCT: Central corneal thickness; ACD: Anterior chamber depth; AL: Axial length


Ocular biometrics assessment in POAG.

POAGNMinimumMaximumMeanSD
Age (years)85408460.2810.42
IOP (mm Hg)85254331.503.50
CCT (mm)850.476605504.60129.29
ACD (mm)852.033.252.570.28
AL (mm)8521.8225.3823.550.79

Pearson correlation for linear regression for baseline IOP and AGIS score in PACG demonstrated correlation coefficient (r) as 0.805, with p-value <0.001. Hence, the correlation is significant and positive [Table/Fig-7]. No such correlation was noted with regard to PSD. Since p-value is >0.05, the correlation is not significant for MD and PSD in POAG [Table/Fig-8].

Correlation of IOP with visual field scores in PACG.

Correlation of IOP with other variables (PACG)NMeanSDPearson correlation coefficient (r)p-value*
MD (dB)25-14.367.570.812<0.001
PSD (dB)258.463.66-0.1580.450
AGIS2510.445.280.805<0.001
CCT (mm)25531.9614.15-0.2330.262
ACD (mm)252.300.440.0130.949
AL (mm)2521.591.15-0.0190.929

Sig 2 tailed test*. IOP: Intraocular pressure; MD: Mean deviation; PSD: Pattern standard deviation; AGIS: Advanced glaucoma intervention score; IOP mean=33.56 mmHg, SD=3.40 mmHg


Correlation of IOP with visual field scores in POAG.

Correlation of IOP with other variables (POAG)NMeanSDPearson correlation coefficient (r)p-value*
MD (dB)85-16.279.61-0.0580.597
PSD (dB)858.124.200.0710.518
AGIS8511.855.650.0260.816
CCT (mm)85504.60129.29-0.0550.616
ACD (mm)852.570.280.1220.266
AL (mm)8523.550.790.0720.511

Sig 2 tailed test*, IOP: Intraocular pressure; MD: Mean deviation; PSD: Pattern standard deviation; AGIS: Advanced glaucoma intervention score; IOP mean=31.5 mmHg, SD=3.50 mmHg


Discussion

An awareness of modifiable and non-modifiable risk factors regarding glaucoma is essential since it is a major cause for blindness worldwide. In present study, most of the patients belong to the age group of 56-70 years. Advancing age is a risk factor for glaucomas [14-16]. This correlates well with the study conducted by Markowitz SN and Morin JD, who also found that there is increased prevalence of pupillary block glaucomas between 50-70 years of age [17]. Because anterior chamber volume/area is the volume/area bounded by the cornea, the iris, and the anterior surface of the lens, the change in anterior chamber area/volume is the composite result of changes in these tissues. As age advances, thickness of lens increases and thus may be an important factor causing the age-related diminution of these parameters [18].

There was no significant gender predisposition observed in the study probably due to the selection criteria of reliability of visual fields rather than incidence. In ocular hypertension study, male gender was found by univariate analysis to be a useful predictor for the onset of POAG [19,20].

A positive family history of glaucoma was noted in 16% of PACG patients and 41.18% of POAG patients. A study by Awadalla MS et al., demonstrated that around 50 percent of POAG patients have a positive family history and their first degree relatives had an approximately nine fold increased risk of developing glaucoma [19]. This study showed that a family history of glaucoma is associated with the presence and severity of PAC and POAG [21].

In the South Indian population screened, siblings of angle-closure patients had a greater than one in three risk of prevalent angle closure, whereas siblings of PAC/PACG patients had a >10% risk of prevalent PAC/PACG. Hence screening siblings of angle-closure patients is likely to detect more cases of angle closure [22]. The contribution of genetics in glaucoma risk prediction limited to the knowledge of family history warrant evaluation in siblings and for early diagnosis [14].

Systemic Hypertension has been noted as a potential risk factor for glaucoma in clinic based studies [23]. Patients using medications for hypertension is also exposed to hypotension and resultant decreased ocular perfusion pressure with IOP, which increases vulnerability to optic nerve damage in open angle glaucoma.

Linear regression analysis demonstrated a significant positive correlation observed between IOP and AGIS score (correlation coefficient, r=0.805 where p<0.001, in PACG group). This suggests that IOP is strongly implicated as a causative factor for optic nerve damage in PACG. This is comparable to the results obtained in the study, IOP and visual field loss in primary angle closure and POAG by Gazzard G et al., which demonstrated significant correlation between IOP and AGIS score in PACG [5].

There was strong positive correlation between IOP and MD where correlation coefficient r=0.812 and p<0.001. Correlation between MD and the more specific AGIS score implies that visual field loss was glaucomatous. Correlation between IOP and PSD was not found statistically significant. In the present study, we have demonstrated a strong correlation between IOP before initiation of treatment and the severity of visual field loss in PACG patients. These measures were based on parameters adjusted according to age related decrease in retinal sensitivity; hence age distribution do not affect the result. In both the groups, patients with miosis and significant cataract were not included in the study. This indicates difference in field severity is not contributed by lens opacity or miosis.

The risk for blindness was also much higher for angle closure glaucoma than for POAG and therefore the benefit is greater for each case of angle-closure glaucoma prevented [24-27]. In POAG, linear regression analysis demonstrated that the correlation between IOP and AGIS score was not statistically significant since p value is more than 0.05. Similarly, MD and PSD did not show significant correlation with IOP. This suggests that IOP alone cannot be considered as a causative factor for optic nerve damage in POAG and also supports the multifactorial etiology of optic nerve damage in POAG. This is comparable to the results obtained in the study, IOP and visual field loss in primary angle closure and POAG by Gazzard G et al., which demonstrated no significant correlation between IOP and AGIS score in POAG. In the present study, we found out that IOP alone was insufficient to explain the severity of visual field loss in POAG hence other modifying factors were more important in POAG [5].

Limitation(s)

Since the study subjects were selected on the basis of reliability of visual field test and other criteria, the study population was not representative of normal population. So the demographic characteristics could not be generalised to normal population. A bias may be created by difference in the number of subjects in POAG and PACG.

Conclusion(s)

The significant correlation between IOP and visual field implies that IOP is a modifiable risk factor in PACG. High incidence of positive family history in POAG highlights the importance of glaucoma screening and follow-up in first degree relatives of POAG patients. The multifactorial pathogenesis of POAG should be further explored.

PACG: Primary angle closure glaucoma; POAG: Primary open angle glaucomaDM: Type 1 Diabetes mellitus; HTN: Systemic hypertension(n=25 in PACG group; n=85 in POAG group)CCT: Central corneal thickness; ACD: Anterior chamber depth; AL: Axial lengthSig 2 tailed test*. IOP: Intraocular pressure; MD: Mean deviation; PSD: Pattern standard deviation; AGIS: Advanced glaucoma intervention score; IOP mean=33.56 mmHg, SD=3.40 mmHgSig 2 tailed test*, IOP: Intraocular pressure; MD: Mean deviation; PSD: Pattern standard deviation; AGIS: Advanced glaucoma intervention score; IOP mean=31.5 mmHg, SD=3.50 mmHg

References

[1]George R, Ve RS, Vijaya L, Glaucoma in India; Estimated burden of disease J Glaucoma 2010 19(6):391-97.10.1097/IJG.0b013e3181c4ac5b20711029  [Google Scholar]  [CrossRef]  [PubMed]

[2]Choudhari NS, George R, Baskaran M, Vijaya L, Dudeja N, Measurement of Goldmann applanation tonometer calibration error Ophthalmology 2008 116(1):03-08.10.1016/j.ophtha.2008.06.02018708256  [Google Scholar]  [CrossRef]  [PubMed]

[3]Singh P, Tyagi M, Kumar Y, Kuldeep K, Sharma PD, Gonioscopy: A review Open Journal of Ophthalmology 2013 03(04):118-21.10.4236/ojoph.2013.34025  [Google Scholar]  [CrossRef]

[4]Artes PH, Iwase A, Ohno Y, Kitazawa Y, Chauhan BC, Properties of perimetric threshold estimates from full threshold, SITA standard, and SITA fast strategies Investigative ophthalmol and Vis Sci Glaucoma 200 43(8):2654-59.  [Google Scholar]

[5]Gazzard G, Foster PJ, Devereux JG, Oen F, Chew P, Khaw PT, Intraocular pressure and visual field loss in primary angle closure and primary open angle glaucomas Br J Ophthalmol 2003 87(6):720-25.10.1136/bjo.87.6.72012770969  [Google Scholar]  [CrossRef]  [PubMed]

[6]Ritch R, Lowe RF, In: Ritch R, Shields MB, Krupin T, eds. The glaucomas 1996 2nd edSt LouisMosby:801-19.  [Google Scholar]

[7]Chang EE, Goldberg JL, Glaucoma 2.0: Neuroprotection, neuroregeneration, neuroenhancement Ophthalmology 2012 119(5):979-86.10.1016/j.ophtha.2011.11.00322349567  [Google Scholar]  [CrossRef]  [PubMed]

[8]Foster PJ, Aung T, Nolan WP, Machin D, Baasanhu J, Khaw PT, Defining “occludable” angles in population surveys: Drainage angle width, peripheral anterior synechiae, and glaucomatous optic neuropathy in east Asian people Br J Ophthalmol 2004 88(4):486-90.10.1136/bjo.2003.02001615031161  [Google Scholar]  [CrossRef]  [PubMed]

[9]Senthilkumari S, Neethu M, Santhi R, Krishnadas SR, Muthukkaruppan V, Identification of glaucomatous optic nerve head changes in Indian donor eyes without clinical history Indian J Ophthalmol 2015 63(7):600-05.10.4103/0301-4738.16711826458478  [Google Scholar]  [CrossRef]  [PubMed]

[10]Yaqub M, Visual fields interpretation in glaucoma: A focus on static automated perimetry Community Eye Health 2012 25(79-80):01-08.  [Google Scholar]

[11]Heo DW, Kim KN, Properties of PSD in open angle glaucoma with hemioptic neuropathy and biopticneuropathy Plosone. [internet] 2017 12(3):017196010.1371/journal.pone.017196028249022  [Google Scholar]  [CrossRef]  [PubMed]

[12]The Advanced Glaucoma intervention study (AGIS): 2 Visual field test scoring and reliability. The AGIS investigators Ophthalmology 1994 101(8):1445-55.10.1016/S0161-6420(94)31171-7  [Google Scholar]  [CrossRef]

[13]Vesti E, Johnson CA, Chauhan BC, Comparison of different methods for detecting glaucomatous visual field progression Invest Ophthalmol Vis Sci 2003 44(9):3873-79.10.1167/iovs.02-117112939303  [Google Scholar]  [CrossRef]  [PubMed]

[14]Actis AG, Versino E, Risk factors for POAG progression: A Study ruled in Torino 2016 Openophthalmology Journal 2016 10:129-39.10.2174/187436410161001012927347249  [Google Scholar]  [CrossRef]  [PubMed]

[15]Senthil S, Garudadri C, Angle closure in the Andhra Pradesh eye disease study Ophthalmology 2010 117(9):1729-35.10.1016/j.ophtha.2010.01.02120466426  [Google Scholar]  [CrossRef]  [PubMed]

[16]Chauhan BC, Mikelberg FS, Canadian glaucoma study. Risk factors for progression of open angle glaucoma Arch Ophthalmol 2008 126(8):1030-36.10.1001/archopht.126.8.103018695095  [Google Scholar]  [CrossRef]  [PubMed]

[17]Markowitz SN, Morin JD, Angle-closure glaucoma: Relation between lens thickness, anterior chamber depth and age Can J Ophthalmol 1984 19(7):300-02.  [Google Scholar]

[18]Wu RY, Nongpiur ME, He MG, Sakata LM, Friedman DS, Chan YH, Association of narrow angles with anterior chamber area and volume measured with anterior-segment optical coherence tomography Arch Ophthalmol 2011 129(5):569-74.10.1001/archophthalmol.2011.6821555608  [Google Scholar]  [CrossRef]  [PubMed]

[19]Awadalla MS, Fingert JH, Roos BE, Chen S, Holmes R, Graham SL, Copy number variations of TBK1 in Australian patients with primary open-angle glaucoma Am J Ophthamol 2015 159:124-30.Epub 2014 Oct 210.1016/j.ajo.2014.09.04425284765  [Google Scholar]  [CrossRef]  [PubMed]

[20]Flammer J, Pache M, Vasopasm RT, Its role in the pathogenesis of diseases with particular reference to the eye Prog Retine Eye Res 2001 20(3):319-49.10.1016/S1350-9462(00)00028-8  [Google Scholar]  [CrossRef]

[21]Kong X, Chen Y, Chen X, Sun X, Influence of family history as a risk factor on primary angle closure and primary open angle glaucoma in a Chinese population Ophthalmic Epidemiol 2011 18(5):226-32.10.3109/09286586.2011.59504021961512  [Google Scholar]  [CrossRef]  [PubMed]

[22]Kavitha S, Zebardast N, Palaniswamy K, Wojciechowski R, Chan ES, Friedman DS, Family history is a strong risk factor for prevalent angleclosure in a South Indian population Comparative Ophthalmology 2014 121(11):2091-97.10.1016/j.ophtha.2014.05.00124974379  [Google Scholar]  [CrossRef]  [PubMed]

[23]McMonnies CW, Glaucoma history and risk factors Journal of Optometry 2017 10(2):71-78.10.1016/j.optom.2016.02.00327025415   [Google Scholar]  [CrossRef]  [PubMed]

[24]Buhrmann RR, Quigley HA, Barron Y, West SK, Oliva MS, Mmbaga BB, Prevalence of glaucoma in a rural East African population Invest Ophthalmol Vis Sci 2000 41(1):40-48.  [Google Scholar]

[25]Foster PJ, Baasanhu J, Alsbirk PH, Munkhbayar D, Uranchimeg D, Johnson GJ, Glaucoma in Mongolia. A population-based survey in Hovsgol province, northern Mongolia Arch Ophthalmol 1996 114(10):1235-41.10.1001/archopht.1996.011001404350118859083  [Google Scholar]  [CrossRef]  [PubMed]

[26]Foster PJ, Oen FT, Machin D, Ng TP, Devereux JG, Johnson GJ, The prevalence of glaucoma in Chinese residents of Singapore: A cross-sectional population survey of the Tanjong Pagar district Arch Ophthalmol 2000 118(8):1105-11.10.1001/archopht.118.8.110510922206  [Google Scholar]  [CrossRef]  [PubMed]

[27]Le A, Mukesh BN, McCarty CA, Taylor HR, Risk factors associated with the incidence of open-angle glaucoma: The visual impairment project Invest Ophthalmol Vis Sci 2003 44(9):3783-89.10.1167/iovs.03-007712939292  [Google Scholar]  [CrossRef]  [PubMed]